科研製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/09/01 | 3,560 | 3,586 | 3,535 | 3,573 | -7 | -0.2% | 162,300 |
2023/08/31 | 3,573 | 3,602 | 3,544 | 3,580 | +4 | +0.1% | 162,200 |
2023/08/30 | 3,548 | 3,591 | 3,543 | 3,576 | +23 | +0.6% | 427,300 |
2023/08/29 | 3,550 | 3,553 | 3,515 | 3,553 | -1 | ±0% | 256,700 |
2023/08/28 | 3,568 | 3,578 | 3,554 | 3,554 | -2 | -0.1% | 81,900 |
2023/08/25 | 3,556 | 3,574 | 3,550 | 3,556 | +8 | +0.2% | 86,700 |
2023/08/24 | 3,520 | 3,555 | 3,512 | 3,548 | ±0 | ±0% | 81,700 |
2023/08/23 | 3,535 | 3,554 | 3,530 | 3,548 | -9 | -0.3% | 72,800 |
2023/08/22 | 3,544 | 3,565 | 3,523 | 3,557 | +13 | +0.4% | 80,800 |
2023/08/21 | 3,555 | 3,580 | 3,523 | 3,544 | -3 | -0.1% | 153,500 |
2023/08/18 | 3,506 | 3,566 | 3,504 | 3,547 | +25 | +0.7% | 144,700 |
2023/08/17 | 3,575 | 3,575 | 3,510 | 3,522 | -47 | -1.3% | 188,600 |
2023/08/16 | 3,556 | 3,582 | 3,541 | 3,569 | -12 | -0.3% | 105,700 |
2023/08/15 | 3,599 | 3,615 | 3,573 | 3,581 | -18 | -0.5% | 85,800 |
2023/08/14 | 3,601 | 3,633 | 3,582 | 3,599 | -6 | -0.2% | 142,000 |
2023/08/10 | 3,593 | 3,605 | 3,566 | 3,605 | +16 | +0.4% | 115,400 |
2023/08/09 | 3,551 | 3,590 | 3,531 | 3,589 | +44 | +1.2% | 132,500 |
2023/08/08 | 3,538 | 3,560 | 3,528 | 3,545 | +24 | +0.7% | 178,400 |
2023/08/07 | 3,548 | 3,569 | 3,496 | 3,521 | -21 | -0.6% | 191,700 |
2023/08/04 | 3,526 | 3,545 | 3,501 | 3,542 | +16 | +0.5% | 164,300 |
2023/08/03 | 3,519 | 3,552 | 3,502 | 3,526 | -9 | -0.3% | 199,800 |
2023/08/02 | 3,531 | 3,562 | 3,526 | 3,535 | -30 | -0.8% | 131,300 |
2023/08/01 | 3,538 | 3,567 | 3,529 | 3,565 | +24 | +0.7% | 168,500 |
2023/07/31 | 3,539 | 3,543 | 3,509 | 3,541 | +43 | +1.2% | 288,200 |
2023/07/28 | 3,465 | 3,505 | 3,454 | 3,498 | +3 | +0.1% | 186,800 |
2023/07/27 | 3,483 | 3,495 | 3,474 | 3,495 | +2 | +0.1% | 169,600 |
2023/07/26 | 3,492 | 3,499 | 3,479 | 3,493 | -9 | -0.3% | 141,400 |
2023/07/25 | 3,515 | 3,516 | 3,491 | 3,502 | -20 | -0.6% | 103,600 |
2023/07/24 | 3,538 | 3,546 | 3,517 | 3,522 | +21 | +0.6% | 77,800 |
2023/07/21 | 3,488 | 3,509 | 3,483 | 3,501 | +13 | +0.4% | 87,000 |
2023/07/20 | 3,531 | 3,533 | 3,486 | 3,488 | -45 | -1.3% | 149,100 |
2023/07/19 | 3,522 | 3,533 | 3,498 | 3,533 | +30 | +0.9% | 108,800 |
2023/07/18 | 3,503 | 3,532 | 3,490 | 3,503 | +7 | +0.2% | 78,500 |
2023/07/14 | 3,488 | 3,498 | 3,474 | 3,496 | +10 | +0.3% | 133,700 |
2023/07/13 | 3,500 | 3,511 | 3,482 | 3,486 | -14 | -0.4% | 103,300 |
2023/07/12 | 3,499 | 3,514 | 3,481 | 3,500 | -1 | ±0% | 120,100 |
2023/07/11 | 3,529 | 3,536 | 3,491 | 3,501 | -31 | -0.9% | 185,300 |
2023/07/10 | 3,535 | 3,551 | 3,519 | 3,532 | -13 | -0.4% | 126,700 |
2023/07/07 | 3,552 | 3,573 | 3,537 | 3,545 | -23 | -0.6% | 85,000 |
2023/07/06 | 3,573 | 3,602 | 3,560 | 3,568 | -20 | -0.6% | 121,100 |
2023/07/05 | 3,574 | 3,600 | 3,562 | 3,588 | +26 | +0.7% | 96,300 |
2023/07/04 | 3,600 | 3,608 | 3,500 | 3,562 | -60 | -1.7% | 248,700 |
2023/07/03 | 3,620 | 3,649 | 3,610 | 3,622 | +20 | +0.6% | 83,100 |
2023/06/30 | 3,630 | 3,639 | 3,596 | 3,602 | -37 | -1% | 114,100 |
2023/06/29 | 3,677 | 3,677 | 3,627 | 3,639 | -39 | -1.1% | 69,500 |
2023/06/28 | 3,616 | 3,678 | 3,616 | 3,678 | +49 | +1.4% | 90,500 |
2023/06/27 | 3,646 | 3,646 | 3,610 | 3,629 | -17 | -0.5% | 78,800 |
2023/06/26 | 3,657 | 3,667 | 3,611 | 3,646 | -7 | -0.2% | 42,900 |
2023/06/23 | 3,670 | 3,673 | 3,635 | 3,653 | -18 | -0.5% | 64,500 |
2023/06/22 | 3,673 | 3,695 | 3,666 | 3,671 | +3 | +0.1% | 63,400 |
301~
350
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
科研薬 | 446,100円 | +22.8% | +113.0% | 4.26% | 11.90倍 | 1.09倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
サワイGHD | 197,200円 | +4.0% | +25.4% | 2.69% | 9.11倍 | 1.20倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
住友ファーマ | 60,900円 | +7.5% | - | 0.00% | - | 2.12倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
キッセイ薬 | 365,500円 | +14.5% | -2.3% | 2.46% | 13.37倍 | 0.71倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
東和薬品 | 282,000円 | +15.0% | -7.3% | 2.13% | 9.25倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム